Guillain-Barré Syndrome Added to Warning to GSK’s Shingles Vaccine
The FDA has required GSK to add the warning that post-marketing observational studies revealed an increased risk of Guillain-Barré Syndrome in recipients of their shingles vaccine Shingrix, although as per usual, GSK is not required to do anything about it, other than include it on the insert. Vaccine manufacturers are not required to take any […]
Guillain-Barré Syndrome Added to Warning to GSK’s Shingles Vaccine Read More »